| Literature DB >> 11401196 |
D L Hassenzahl1, N K Yorgey, M D Keedy, A R Price, J A Hall, C C Myzcka, H G Kuruvilla.
Abstract
Pituitary adenylate cyclase-activating peptide and lysozyme are potent chemorepellents which act through the same receptor in Tetrahymena. Using in vivo behavioral studies, we have found that the pituitary adenylate cyclase-activating peptide/lysozyme receptor appears to signal through a G-protein pathway which is mediated through both adenosine 3'5'monophosphate and protein kinase C. Avoidance to pituitary adenylate cyclase-activating peptide and lysozyme is inhibited by the G-protein inhibitor, guanosine 5'-O-(2thiodiphosphate), the adenosine 3'5'monophate analog, Rp-adenosine-3', 5' cyclic monophosphorothioate, and the protein kinase C inhibitors, calphostin C and bisindolylmaleimide IV. A proposed model for signaling through the pituitary adenylate cyclase-activating peptide/lysozyme receptor is briefly outlined.Entities:
Mesh:
Substances:
Year: 2001 PMID: 11401196 DOI: 10.1007/s003590100185
Source DB: PubMed Journal: J Comp Physiol A Impact factor: 1.836